Vasopharm’s ronopterin fails in traumatic brain injury trial
Austria
Telix doses first subject in Phase II glioblastoma therapy trial
This Phase II trial builds on data from the IPAX-1 study reported in September this year.
Novo Nordisk’s somapacitan shows favourable profile in GHD trial
Computer simulation offers digital penicillin production
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox